Skip to content
Boca Raton City Online – Lifestyle
Author:
Atrium Therapeutics
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 20, 2026
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
Bronx Criminal Defense Attorney David Mejia Colgan Outlines How Domestic Violence Assault Charges Are Prosecuted Under New York Penal Law
June 26, 2026
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 23, 2026
Bronx Criminal Defense Attorney David Colgan Explains How Criminal Obstruction of Breathing Is Charged Under NY Penal Law § 121.11
June 17, 2026
Atrium Therapeutics Reports First Quarter 2026 Financial Results
May 14, 2026
Bronx Domestic Violence Defense Attorney David Mejia Colgan Details Defense Strategies for First-Degree Strangulation Charges Under PL § 121.13
May 3, 2026
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
April 23, 2026
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 20, 2026